Argenx announces launch of proposed global offering

Regulated information — inside information argenx announces launch of proposed global offering july 17 , 2023 amsterdam , the netherlands — argenx se (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced today that it has commenced a global offering of $750 million (approximately €668.6 million) of ordinary shares, which may be represented by american depository shares (“adss”). the global offering will be comprised of an offering of ordinary shares represented by adss in the united states and certain other countries outside of the european economic area and a simultaneous private placement of ordinary shares in the european economic area and the united kingdom.
ARGX Ratings Summary
ARGX Quant Ranking